about
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trialHalf of U.K. patients with rheumatoid arthritis are prescribed oral glucocorticoid therapy in primary care: a retrospective drug utilisation study.Survival rate of breast cancer based on geographical variation in iran, a national studyRisk of Incident Diabetes Mellitus Associated With the Dosage and Duration of Oral Glucocorticoid Therapy in Patients With Rheumatoid ArthritisOral glucocorticoid therapy and all-cause and cause-specific mortality in patients with rheumatoid arthritis: a retrospective cohort studySmoking-Related Mortality in Patients With Early Rheumatoid Arthritis: A Retrospective Cohort Study Using the Clinical Practice Research Datalink.Predictors of patient decision to discontinue anti-rheumatic medication in patients with rheumatoid arthritis: results from the Ontario best practices research initiative.Risks of smoking and benefits of smoking cessation on hospitalisations for cardiovascular events and respiratory infection in patients with rheumatoid arthritis: a retrospective cohort study using the Clinical Practice Research Datalink.Temporal variations of health indicators in Iran comparing with other Eastern Mediterranean Region countries in the last two decades.Trends and geographical inequalities of the main health indicators for rural Iran.Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trialSocioeconomic status and colorectal cancer incidence by anatomical subsiteParity and breastfeeding are preventive measures against breast cancer in Iranian womenModified Disease Activity Score at 3 Months Is a Significant Predictor for Rapid Radiographic Progression at 12 Months Compared With Other Measures in Patients With Rheumatoid ArthritisCollection of antirheumatic medication data from both patients and rheumatologists shows strong agreement in a real-world clinical cohort: the Ontario Best Practices Research Initiative-a rheumatoid arthritis cohort
P50
Q35627411-FCE1A325-D8A5-4D25-9A0B-D636363A5459Q36477420-E8B497F1-EC56-40AD-AFCB-FD5D915F0610Q36655552-3E79EF3D-C1F9-4945-B47F-8711FFDEB089Q37169479-458A3570-30CA-4A05-80B4-C56E996E37AFQ37341911-53CD6A41-322D-4675-86B4-3A8BCD82DEDCQ37388189-157E24DC-795A-49BA-ADE7-02AA57A34508Q40503217-24107852-B51C-4112-9880-9BA26C11CEC3Q42016828-EC9F9B47-E519-4F1E-9B42-7C628D36B8E5Q44893497-E7A9A8B8-6ABD-4324-AA1B-D182DD60F3CFQ46334302-4EA57769-50ED-437F-BB33-A70E2B15BFA6Q56435837-7736F9F2-8714-4106-B3CB-D3DE00F644B1Q56707599-381FA3D9-13C3-48DD-93F8-A71CB0FDADACQ57578673-C2268404-8D55-4C7D-9531-3E4BCB986A45Q90321904-A1C77894-CDF9-44DB-BD20-36E71A9745A4Q92938575-F550C63E-841E-4422-BA95-9B64AC9C4B7C
P50
description
researcher
@en
researcher
@en-ca
researcher
@en-gb
wetenschapper
@nl
ymchwilydd
@cy
հետազոտող
@hy
name
Mohammad Movahedi
@ast
Mohammad Movahedi
@cy
Mohammad Movahedi
@de
Mohammad Movahedi
@en
Mohammad Movahedi
@en-ca
Mohammad Movahedi
@en-gb
Mohammad Movahedi
@es
Mohammad Movahedi
@fr
Mohammad Movahedi
@it
Mohammad Movahedi
@nl
type
label
Mohammad Movahedi
@ast
Mohammad Movahedi
@cy
Mohammad Movahedi
@de
Mohammad Movahedi
@en
Mohammad Movahedi
@en-ca
Mohammad Movahedi
@en-gb
Mohammad Movahedi
@es
Mohammad Movahedi
@fr
Mohammad Movahedi
@it
Mohammad Movahedi
@nl
prefLabel
Mohammad Movahedi
@ast
Mohammad Movahedi
@cy
Mohammad Movahedi
@de
Mohammad Movahedi
@en
Mohammad Movahedi
@en-ca
Mohammad Movahedi
@en-gb
Mohammad Movahedi
@es
Mohammad Movahedi
@fr
Mohammad Movahedi
@it
Mohammad Movahedi
@nl
P106
P1153
26534703300
57021309000
P21
P213
0000 0001 3428 2024
P31
P496
0000-0001-6154-0121